This week we featured two posts from PhRMA's President and CEO John Castellani, both of which looked at the global challenges facing the pharmaceutical industry.
The National Institute for Allergy and Infectious Diseases yesterday put out a great new video about the prescription drug discovery process which emphasized the importance of medical innovation partnerships.
Reading Matthew Yglesias' post in Slate on Thursday about why Medicare Part D costs less than predicted, I found his argument a bit odd.
Today's House Ways and Means Trade Subcommittee hearing on U.S. - India trade relations could not be more timely.
Congratulations to Dr. Juan Lertora, the 2013 recipient of Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation Award in Excellence in Clinical Pharmacology.
I explored a new study from the National Bureau of Economic Research (NBER) today and was encouraged by its balanced views on direct to consumer advertising (DTC), including recognition that DTC advertising helps
Last week's op-ed in the Washington Post ("Making cancer drugs less expensive") highlighted some important issues r
A commentary posted today on Forbes nicely captures the vital importance of well-funded basic biomedical r
03.04.13 | By Jay Taylor
03.04.13 | By Mark Grayson